131 related articles for article (PubMed ID: 16580388)
1. Hyperinsulinemia and circulating dehydroepiandrosterone sulfate in white and Mexican American women with polycystic ovary syndrome.
Kauffman RP; Baker VM; DiMarino P; Castracane VD
Fertil Steril; 2006 Apr; 85(4):1010-6. PubMed ID: 16580388
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS).
Kumar A; Woods KS; Bartolucci AA; Azziz R
Clin Endocrinol (Oxf); 2005 Jun; 62(6):644-9. PubMed ID: 15943823
[TBL] [Abstract][Full Text] [Related]
3. Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome.
Azziz R; Ehrmann DA; Legro RS; Fereshetian AG; O'Keefe M; Ghazzi MN;
Fertil Steril; 2003 Apr; 79(4):932-7. PubMed ID: 12749433
[TBL] [Abstract][Full Text] [Related]
4. Opposing effects of dehydroepiandrosterone sulfate and free testosterone on metabolic phenotype in women with polycystic ovary syndrome.
Lerchbaum E; Schwetz V; Giuliani A; Pieber TR; Obermayer-Pietsch B
Fertil Steril; 2012 Nov; 98(5):1318-25.e1. PubMed ID: 22835450
[TBL] [Abstract][Full Text] [Related]
5. Association of CYP3A7*1C and serum dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome.
Goodarzi MO; Xu N; Azziz R
J Clin Endocrinol Metab; 2008 Jul; 93(7):2909-12. PubMed ID: 18445661
[TBL] [Abstract][Full Text] [Related]
6. Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: a comparison of two distinct populations.
Kauffman RP; Baker VM; Dimarino P; Gimpel T; Castracane VD
Am J Obstet Gynecol; 2002 Nov; 187(5):1362-9. PubMed ID: 12439532
[TBL] [Abstract][Full Text] [Related]
7. Androsterone glucuronide to dehydroepiandrosterone sulphate ratio is discriminatory for obese Caucasian women with polycystic ovary syndrome.
Cho LW; Sathyapalan T; Kilpatrick ES; Keevil BG; Miller AG; Coady AM; Ahmed L; Atkin SL
BMC Endocr Disord; 2017 May; 17(1):26. PubMed ID: 28525998
[TBL] [Abstract][Full Text] [Related]
8. Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome.
Brennan K; Huang A; Azziz R
Fertil Steril; 2009 May; 91(5):1848-52. PubMed ID: 18439591
[TBL] [Abstract][Full Text] [Related]
9. Effects of Metformin Treatment on Soluble Leptin Receptor Levels in Women with Polycystic Ovary Syndrome.
Liu RB; Liu Y; Lv LQ; Xiao W; Gong C; Yue JX
Curr Med Sci; 2019 Aug; 39(4):609-614. PubMed ID: 31346998
[TBL] [Abstract][Full Text] [Related]
10. Impact of overnight dexamethasone suppression on the adrenal androgen response to an oral glucose tolerance test in women with and without polycystic ovary syndrome.
Buyalos RP; Geffner ME; Azziz R; Judd HL
Hum Reprod; 1997 Jun; 12(6):1138-41. PubMed ID: 9221990
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein profiles in Mexican American and non-Hispanic white women with polycystic ovary syndrome.
Kauffman RP; Baker TE; Graves-Evenson K; Baker VM; Castracane VD
Fertil Steril; 2011 Dec; 96(6):1503-7. PubMed ID: 21982731
[TBL] [Abstract][Full Text] [Related]
12. Role of the follistatin gene in women with polycystic ovary syndrome.
Calvo RM; Villuendas G; Sancho J; San Millán JL; Escobar-Morreale HF
Fertil Steril; 2001 May; 75(5):1020-3. PubMed ID: 11334920
[TBL] [Abstract][Full Text] [Related]
13. ACTH stimulation test in lean polycystic ovary syndrome patients with insulin resistance.
Uncu G; Ozyurek SE; Uncu Y
Fertil Steril; 2007 Sep; 88(3):670-4. PubMed ID: 17451692
[TBL] [Abstract][Full Text] [Related]
14. DHEA, DHEAS and PCOS.
Goodarzi MO; Carmina E; Azziz R
J Steroid Biochem Mol Biol; 2015 Jan; 145():213-25. PubMed ID: 25008465
[TBL] [Abstract][Full Text] [Related]
15. Heritability of dehydroepiandrosterone sulfate in women with polycystic ovary syndrome and their sisters.
Yildiz BO; Goodarzi MO; Guo X; Rotter JI; Azziz R
Fertil Steril; 2006 Dec; 86(6):1688-93. PubMed ID: 17074350
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess.
Witchel SF; Kahsar-Miller M; Aston CE; White C; Azziz R
Fertil Steril; 2005 Feb; 83(2):371-5. PubMed ID: 15705377
[TBL] [Abstract][Full Text] [Related]
17. Myostatin and its association with abdominal obesity, androgen and follistatin levels in women with polycystic ovary syndrome.
Chen MJ; Han DS; Yang JH; Yang YS; Ho HN; Yang WS
Hum Reprod; 2012 Aug; 27(8):2476-83. PubMed ID: 22693174
[TBL] [Abstract][Full Text] [Related]
18. Plasma selenium levels in Turkish women with polycystic ovary syndrome.
Coskun A; Arikan T; Kilinc M; Arikan DC; Ekerbiçer HÇ
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):183-6. PubMed ID: 23490536
[TBL] [Abstract][Full Text] [Related]
19. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
Ardawi MS; Rouzi AA
Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
[TBL] [Abstract][Full Text] [Related]
20. Atorvastatin therapy decreases androstenedione and dehydroepiandrosterone sulphate concentrations in patients with polycystic ovary syndrome: randomized controlled study.
Sathyapalan T; Smith KA; Coady AM; Kilpatrick ES; Atkin SL
Ann Clin Biochem; 2012 Jan; 49(Pt 1):80-5. PubMed ID: 21972424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
